Anterior Gradient 3 (AGR3) is a biomarker for cancer research, and a novel biomarker for ovarian cancer that mediates cisplatin resistance in xenograft models.
Features
Size: 50ug Please refer to AGR3/BCMP11 (Human) Recombinant #00530-01-100 for more information.